يعرض 101 - 120 نتائج من 14,881 نتيجة بحث عن '(( significant increases decrease ) OR ( significant ((teer decrease) OR (we decrease)) ))', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 101

    PRISMA flow diagram. حسب Martha R. Smith (20410184)

    منشور في 2024
    الموضوعات:
  2. 102

    S9 File - حسب Martha R. Smith (20410184)

    منشور في 2024
    الموضوعات:
  3. 103

    S7 File - حسب Martha R. Smith (20410184)

    منشور في 2024
    الموضوعات:
  4. 104
  5. 105

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  6. 106

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  7. 107

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112

    Sociodemographic characteristics. حسب Hea Ree Park (10769827)

    منشور في 2024
    الموضوعات:
  13. 113

    Study flow chart. حسب Hea Ree Park (10769827)

    منشور في 2024
    الموضوعات:
  14. 114

    Cohort characteristics. حسب Vincent Pey (21433304)

    منشور في 2025
    "…</p><p>Results</p><p>Upon initiation of CPB we observed a significant decrease in arterial whole blood redox potential (101.90 mV + /- 11.52 vs. 41.80 mV + /- 10,26; p < 0.0001). …"
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119

    Summary of measured parameters. حسب Aaron L. Sayler (19797446)

    منشور في 2025
    الموضوعات:
  20. 120

    Raw data. حسب Aaron L. Sayler (19797446)

    منشور في 2025
    الموضوعات: